Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti

Dr. Arpaporn Sutipatanasomboon is experienced in cell biology and molecular genetics research and is a registered patent agent with the Thailand Department of Intellectual Property. Her passion is to integrate early health technology assessment and intellectual property management to support decision makers, innovators and promote access to innovat

For the first time, researchers have determined virtually the entire genome of a fetus using only a blood sample from the pregnant woman and a saliva specimen from the father.The accomplishment heralds an era in which parents might find it easier to know the complete DNA blueprint of a child months

Abstract Aim This systematic review aimed to ascertain the diagnostic accuracy (sensitivity and specificity) of screening tests for early detection of type 2 diabetes and prediabetes in previously undiagnosed adults. Methods This systematic review included published studies that included one

Thai Health Technology Assessment (HTA) Database was initially developed in 2008 and aimed to improve accessibility of HTA information. In this Phase II study, the database is extending the type of research articles. Consequently, 4 types of studies which are full economic evaluation, randomized controlled trial, quality of life and cost of illness

The project’s objective is to develop a database for health technology assessment in Thailand. The database includes research studies related to the Thai context published in either Thai or English. The research studies’ quality will be evaluated to provide readers with its advantages and disadvantages in order that researchers can make appropr

Because the quality of cost-effectiveness studies related to the Thai context is still limited, the Thai health technology assessment guidelines have been firstly developed in Thailand for researchers to stimulate the provision of standardized, reliable and good quality information which can be used by policy makers and healthcare personnel for mak

Although HITAP strictly follows national HTA methodological guidelines, questions over the good governance of research arose from a lack of formal process guidelines. Therefore, HITAP embarked on the development of HTA process guidelines in 2011. International guidelines were reviewed in order to develop a conceptual framework, with the aim of conn

The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve